PYCR1: Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +) |
m Bot: HTTP→HTTPS |
||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
{{ | '''Pyrroline-5-carboxylate reductase 1, mitochondrial''' is an [[enzyme]] that in humans is encoded by the ''PYCR1'' [[gene]].<ref name="pmid1730675">{{cite journal | vauthors = Dougherty KM, Brandriss MC, Valle D | title = Cloning human pyrroline-5-carboxylate reductase cDNA by complementation in Saccharomyces cerevisiae | journal = J Biol Chem | volume = 267 | issue = 2 | pages = 871–5 |date=Feb 1992 | pmid = 1730675 | pmc = | doi = }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: PYCR1 pyrroline-5-carboxylate reductase 1| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5831| accessdate = }}</ref> | ||
}} | |||
| | |||
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. --> | <!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. --> | ||
{{PBB_Summary | {{PBB_Summary | ||
| section_title = | | section_title = | ||
| summary_text = This gene encodes an enzyme that catalyzes the NAD(P)H-dependent conversion of pyrroline-5-carboxylate to proline. This enzyme may also play a physiologic role in the generation of NADP(+) in some cell types. The protein forms a homopolymer and localizes to the mitochondrion. Alternate splicing results in two transcript variants encoding different isoforms.<ref name="entrez" | | summary_text = This gene encodes an enzyme that catalyzes the NAD(P)H-dependent conversion of [[pyrroline-5-carboxylate]] to [[proline]]. This enzyme may also play a physiologic role in the generation of NADP(+) in some cell types. The protein forms a homopolymer and localizes to the mitochondrion. Alternate splicing results in two transcript variants encoding different isoforms.<ref name="entrez" /> | ||
}} | }} | ||
==References== | ==References== | ||
{{reflist | {{reflist}} | ||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
{{PBB_Further_reading | {{PBB_Further_reading | ||
| citations = | | citations = | ||
*{{cite journal | | *{{cite journal | vauthors=Herzfeld A, Legg MA, Greengard O |title=Human colon tumors: enzymic and histological characteristics |journal=Cancer |volume=42 |issue= 3 |pages= 1280–3 |year= 1978 |pmid= 212173 |doi=10.1002/1097-0142(197809)42:3<1280::AID-CNCR2820420337>3.0.CO;2-P }} | ||
*{{cite journal | vauthors=Merrill MJ, Yeh GC, Phang JM |title=Purified human erythrocyte pyrroline-5-carboxylate reductase. Preferential oxidation of NADPH |journal=J. Biol. Chem. |volume=264 |issue= 16 |pages= 9352–8 |year= 1989 |pmid= 2722838 |doi= }} | |||
*{{cite journal | | *{{cite journal |vauthors=Yeh GC, Roth EF, Phang JM, etal |title=The effect of pyrroline-5-carboxylic acid on nucleotide metabolism in erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient subjects |journal=J. Biol. Chem. |volume=259 |issue= 9 |pages= 5454–8 |year= 1984 |pmid= 6201483 |doi= }} | ||
*{{cite journal | *{{cite journal | vauthors=Herzfeld A, Greengard O |title=Enzyme activities in human fetal and neoplastic tissues |journal=Cancer |volume=46 |issue= 9 |pages= 2047–54 |year= 1981 |pmid= 6253048 |doi=10.1002/1097-0142(19801101)46:9<2047::AID-CNCR2820460924>3.0.CO;2-Q }} | ||
*{{cite journal | | *{{cite journal | vauthors=Yeh GC, Harris SC, Phang JM |title=Pyrroline-5-carboxylate reductase in human erythrocytes |journal=J. Clin. Invest. |volume=67 |issue= 4 |pages= 1042–6 |year= 1981 |pmid= 6894153 |doi=10.1172/JCI110115 | pmc=370662 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides |journal=Gene |volume=138 |issue= 1–2 |pages= 171–4 |year= 1994 |pmid= 8125298 |doi=10.1016/0378-1119(94)90802-8 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Basch JJ, Wickham ED, Farrell HM |title=Pyrroline-5-carboxylate reductase in lactating bovine mammary glands |journal=J. Dairy Sci. |volume=79 |issue= 8 |pages= 1361–8 |year= 1997 |pmid= 8880459 |doi=10.3168/jds.S0022-0302(96)76493-7 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, etal |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library |journal=Gene |volume=200 |issue= 1–2 |pages= 149–56 |year= 1997 |pmid= 9373149 |doi=10.1016/S0378-1119(97)00411-3 }} | ||
*{{cite journal | *{{cite journal |vauthors=Strausberg RL, Feingold EA, Grouse LH, etal |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 }} | ||
*{{cite journal | *{{cite journal |vauthors=Gerhard DS, Wagner L, Feingold EA, etal |title=The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC) |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 | pmc=528928 }} | ||
*{{cite journal | *{{cite journal |vauthors=Meng Z, Lou Z, Liu Z, etal |title=Crystal structure of human pyrroline-5-carboxylate reductase |journal=J. Mol. Biol. |volume=359 |issue= 5 |pages= 1364–77 |year= 2006 |pmid= 16730026 |doi= 10.1016/j.jmb.2006.04.053 }} | ||
*{{cite journal | |||
}} | }} | ||
{{refend}} | {{refend}} | ||
{{PDB Gallery|geneid=5831}} | |||
{{Amino acid metabolism enzymes}} | |||
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. --> | |||
{{PBB_Controls | |||
| update_page = yes | |||
| require_manual_inspection = no | |||
| update_protein_box = yes | |||
| update_summary = yes | |||
| update_citations = yes | |||
}} | |||
{{ | {{gene-17-stub}} | ||
Latest revision as of 19:02, 7 September 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Pyrroline-5-carboxylate reductase 1, mitochondrial is an enzyme that in humans is encoded by the PYCR1 gene.[1][2]
This gene encodes an enzyme that catalyzes the NAD(P)H-dependent conversion of pyrroline-5-carboxylate to proline. This enzyme may also play a physiologic role in the generation of NADP(+) in some cell types. The protein forms a homopolymer and localizes to the mitochondrion. Alternate splicing results in two transcript variants encoding different isoforms.[2]
References
Further reading
- Herzfeld A, Legg MA, Greengard O (1978). "Human colon tumors: enzymic and histological characteristics". Cancer. 42 (3): 1280–3. doi:10.1002/1097-0142(197809)42:3<1280::AID-CNCR2820420337>3.0.CO;2-P. PMID 212173.
- Merrill MJ, Yeh GC, Phang JM (1989). "Purified human erythrocyte pyrroline-5-carboxylate reductase. Preferential oxidation of NADPH". J. Biol. Chem. 264 (16): 9352–8. PMID 2722838.
- Yeh GC, Roth EF, Phang JM, et al. (1984). "The effect of pyrroline-5-carboxylic acid on nucleotide metabolism in erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient subjects". J. Biol. Chem. 259 (9): 5454–8. PMID 6201483.
- Herzfeld A, Greengard O (1981). "Enzyme activities in human fetal and neoplastic tissues". Cancer. 46 (9): 2047–54. doi:10.1002/1097-0142(19801101)46:9<2047::AID-CNCR2820460924>3.0.CO;2-Q. PMID 6253048.
- Yeh GC, Harris SC, Phang JM (1981). "Pyrroline-5-carboxylate reductase in human erythrocytes". J. Clin. Invest. 67 (4): 1042–6. doi:10.1172/JCI110115. PMC 370662. PMID 6894153.
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Basch JJ, Wickham ED, Farrell HM (1997). "Pyrroline-5-carboxylate reductase in lactating bovine mammary glands". J. Dairy Sci. 79 (8): 1361–8. doi:10.3168/jds.S0022-0302(96)76493-7. PMID 8880459.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Meng Z, Lou Z, Liu Z, et al. (2006). "Crystal structure of human pyrroline-5-carboxylate reductase". J. Mol. Biol. 359 (5): 1364–77. doi:10.1016/j.jmb.2006.04.053. PMID 16730026.
This article on a gene on human chromosome 17 is a stub. You can help Wikipedia by expanding it. |